Stock valuation
Skarpa has conducted a valuation of AtrimusRX AB.
AtrimusRX is a company that delivers licensed medications and backordered pharmaceuticals to pharmacies, healthcare providers, and veterinarians. AtrimusRX aims to make it easy and quick to procure and order medications that are not available on the Swedish market.
Team:
Mai-Mai Brändström Björklund
Caroline Eriksson
When you submit the information to us, you agree that we register you in our database.
Notice of interest